Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Cardiovascular Education

Minneapolis Heart Institute Foundation Research Advances Understanding of Health Equity and Outcomes in Fourth-Trimester Care for Women

December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

December 04, 2023

Japan’s PMDA asked for further details on a number of elements included in BioCardia’s CardiAMP preclinical and clinical packages in order to gain approval.

News | Heart Failure

BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approval

November 30, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiov ...

November 30, 2023

Data from all three patients in non-randomized cohort treated with DSR 2.0 indicate safe and effective maintenance of euvolemia without the need for loop diuretics, considerable benefit in cardiorenal status and dramatic improvement in diuretic response and loop diuretic requirements up to 11 weeks post DSR treatment

News | Heart Failure

Sequana Medical Announces Positive Data from Non-randomized Cohort in US Phase 1/2a MOJAVE Study of DSR 2.0 for Treatment of Heart Failure

November 30, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure an ...

November 30, 2023

Impella Improves Survival and Heart Recovery

News | Cardiovascular Clinical Studies

First Patient Enrolled in Abiomed’s RECOVER IV Randomized Controlled Trial of Impella as a Therapy for AMI Cardiogenic Shock

November 28, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces the first patient in the world has been ...

November 28, 2023

First Phase 3 study of TNX-103 in PH-HFpEF patients to start in 4Q 2023 (The LEVEL Study)

News | FDA

Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), Initiation of Phase 3 sites expected 2023

November 27, 2023 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and ...

November 27, 2023

A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of two renal denervation (RDN) systems

News | Artificial Intelligence

Renal HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms

November 22, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-powered medical ...

November 22, 2023

The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient.

News | Cardiovascular Clinical Studies

Trial to Prevent Sudden Death After a Heart Attack Enrolls First Patient

November 22, 2023 — The first clinical trial to challenge the routine implantation of a defibrillator in myocardial ...

November 22, 2023

New partnership paves the way for early diagnosis and intervention to improve cardiovascular outcomes and quality of life for patients

News | ECG

AccurKardia Delivers its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions

November 21, 2023 — AccurKardia, an ECG-led diagnostics software company, announced a multi-year agreement with Lucem ...

November 21, 2023

New data from the ARIES trial show for the first time that an aspirin-free regimen can improve outcomes for people living with the heart pump by reducing hospitalizations without increasing the risk of blood clots

News | Heart Valve Technology

Late-breaking Data Show an Aspirin-free Medication Regimen Benefits People with Abbott’s HeartMate 3 Heart Pump

November 20, 2023 — Abbott announced new late-breaking data that show advanced heart failure patients living with its He ...

November 20, 2023

Team Bath Heart’s artificial heart wins top prize at international engineering & design contest

News | Artificial Heart

Heart of Gold: Bath Student Team Wins World Heart Hackathon Competition

November 20, 2023 — Student engineers from the University of Bath are on top of the world after winning an international ...

November 20, 2023

Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology

News | Renal Denervation

Medtronic Announces FDA Approval of Minimally Invasive Device to Treat Hypertension

November 20, 2023 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and ...

November 20, 2023

News | FDA

Renal Denervation Systems Receive FDA Approval, Revolutionizing Treatment for Uncontrolled Hypertension

November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has ...

November 20, 2023

Investigators in the Smidt Heart Institute found that electrocardiogram changes picked up over time could indicate increased risk

News | Sudden Cardiac Arrest

Cedars-Sinai Investigators Move Closer to Predicting Sudden Cardiac Arrest

November 17, 2023 — Sudden cardiac arrest remains a deadly and complex condition, but investigators in the Smidt Heart ...

November 17, 2023

BioCardia announces that the Food and Drug Administration (FDA) has approved its proposed CardiAMP Heart Failure II study protocol

News | FDA

BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure

November 17, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiova ...

November 17, 2023

Findings will help scientists understand how microgravity impacts the ability of human heart cells to withstand the stresses of space travel

News | Heart Failure

Mount Sinai Bioengineers Send Cardiac Muscle Samples Into Space to Study Heart Cell Biology in Microgravity

November 16, 2023 — Mount Sinai’s Cardiovascular Research Institute is sending bioengineered human heart muscle cells ...

November 16, 2023